SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-20-000072
Filing Date
2020-10-07
Accepted
2020-10-07 08:20:38
Documents
16
Period of Report
2020-10-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kin-20201007.htm   iXBRL 8-K 48786
2 EX-99.1 kindredbioprvaxart1007.htm EX-99.1 14241
3 EX-99.2 centaurprvaxart1007.htm EX-99.2 12323
  Complete submission text file 0001561743-20-000072.txt   272284

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20201007.xsd EX-101.SCH 2565
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20201007_cal.xml EX-101.CAL 713
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20201007_def.xml EX-101.DEF 16701
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20201007_lab.xml EX-101.LAB 30978
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20201007_pre.xml EX-101.PRE 17384
9 EXTRACTED XBRL INSTANCE DOCUMENT kin-20201007_htm.xml XML 14129
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 201228108
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences